3D in vitro models uncover malignant cell intrinsic and extrinsic mechanisms of CAR-T cell resistance in high grade serous ovarian cancer

被引：0
|
作者：
Joy, Joash Dominic
Malacrida, Beatrice
Laforets, Florian
Kotantaki, Panoraia
Maniati, Eleni
Hopkins, Sarah
Garrobo-Calleja, Ianire
Gautrot, Julien
Balkwill, Frances
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4576
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4576
引用
收藏
页数：2
相关论文
共 50 条
  • [21] High throughput drug screening to decipher the mechanisms of trametinib adaptive resistance in low-grade serous ovarian cancer cell lines
    Wong, Kwong-Kwok
    Ng, Chun Wai
    Tsang, Yvonne
    Gershenson, David M.
    CANCER RESEARCH, 2024, 84 (05)
  • [22] 3D organoid models for predicting drug response in platinum-sensitive, high-grade serous ovarian cancer
    Mackay, Helen
    Gien, Lilian
    Buzina, Alla
    Schormann, Wiebke
    Andrews, David
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S219 - S219
  • [23] T cell exhaustion correlates with homologous recombination and determines survival in high grade serous ovarian cancer
    Del, Mathilde
    Salvioni, Anna
    Bataillon, Guillaume
    Michelas, Marie
    Segier, Bertille
    Betrian, Sarah
    Ferron, Gwenael
    Ayyoub, Maha
    Martinez, Alejandra
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A506 - A506
  • [24] Modeling CAR-T Cell Activity against Solid Tumors In Vitro: An Assessment of 2D vs 3D Culture
    McKenna, Mary Kathryn
    Englisch, Alexander
    Woods, Mae Louise
    Brenner, Malcolm K.
    MOLECULAR THERAPY, 2021, 29 (04) : 299 - 300
  • [25] Correlation between Wnt signaling and T-cell infiltration in high-grade serous ovarian cancer
    Goldsberry, W.
    Phillips, R. A., III
    Montgomery, A. M.
    Katre, A. A.
    Doo, D. W.
    Norian, L. A.
    Randall, T.
    Yemelyanova, A.
    Cooper, S. J.
    Arend, R. C.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 72 - 72
  • [26] 3D Bio-printed Breast Tumor Spheroid Models for the Evaluation of Chimeric Antigen Receptor (CAR-T) Cell Therapy
    Anzaldo, Ximena Guadalupe Vasto
    Elghajiji, Aya
    Armstrong, James
    Perriman, Adam
    TISSUE ENGINEERING PART A, 2023, 29 (13-14)
  • [27] Patient-derived cell line models revealed therapeutic targets and molecular mechanisms underlying disease progression of high grade serous ovarian cancer
    Kreuzinger, Caroline
    von der Decken, Isabel
    Wolf, Andrea
    Gamperl, Magdalena
    Koller, Julia
    Karacs, Jasmine
    Pfaffinger, Stephanie
    Bartl, Thomas
    Reinthaller, Alexander
    Grimm, Christoph
    Singer, Christian F.
    Braicu, Elena Ioana
    Cunnea, Paula
    Gourley, Charlie
    Smeets, Dominiek
    Boeckx, Bram
    Lambrechts, Diether
    Perco, Paul
    Horvat, Reinhard
    Berns, Els M. J. J.
    Castillo-Tong, Dan Cacsire
    CANCER LETTERS, 2019, 459 : 1 - 12
  • [28] Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease
    Haley, James
    Tomar, Sunil
    Pulliam, Nicholas
    Xiong, Sen
    Perkins, Susan M.
    Karpf, Adam R.
    Mitra, Sumegha
    Nephew, Kenneth P.
    Mitra, Anirban K.
    ONCOTARGET, 2016, 7 (22) : 32810 - 32820
  • [29] Identification of Malignant Cell Populations Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer Using Single-Cell RNA Sequencing
    Sumitani, Naoki
    Ishida, Kyoso
    Sawada, Kenjiro
    Kimura, Tadashi
    Kaneda, Yasufumi
    Nimura, Keisuke
    CANCERS, 2022, 14 (15)
  • [30] Distinct T cell receptor diversity and integrative analyses of clinically defined high-grade serous ovarian cancer
    Lee, Sanghoon
    Zhao, Li
    Little, Latasha
    Westin, Shannon
    Jazaeri, Amir
    Fleming, Nicole
    Zhang, Jianhua
    Futreal, Andrew
    Sood, Anil
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S138 - S138
12345